Home > Resources > Whitepapers > Creating New Value for Biopharma

Creating New Value for Biopharma

The biopharma industry has primarily relied on product-led value creation. This has been driven by price and volume maximisation of innovative medicines, and operating cost base reduction. We believe an alternative focus is required to ensure value creation in the longer term.

Spotlight

Transplant For Life

Transplant For Life is an FDA registered Transplant Tissue Bank. We are dedicated to enhancing lives in our community through facilitating the gift of transplant donation. Located in Phoenix Arizona, Transplant For Life recovers the necessary tissues to restore sight to those that have vision impairment, to treat the wounds of burn victims, and to repair musculoskeletal deformities/injuries to restore mobility. Transplant For Life works with tissue processors within our community to promote the local need of transplantable tissues in our own backyard.

OTHER WHITEPAPERS

Recruitment, Retention & Diversity: The Evolution of Patient Engagement in Clinical Trials

whitePaper | January 23, 2023

Recruitment, retention, and diversity are critical elements of clinical trials that, if insufficient, can jeopardize successful trial completion.

IoT To The Rescue For Biotech & Pharma Manufacturing

whitePaper | April 7, 2020

The Internet of Things (IoT) could not be timelier for biotech/pharma. With fierce cost pressures, the push for value-based outcomes, and the need for flexible manufacturing solutions, the IoT is the much-needed shot in the arm to bring about transformational change. Sensors, actuators, and devices (“things”) embedded in production equipment and networked through computer systems can generate an enormous amount of data. The data can be mined for insights and opportunities to drive production efficiency, automate monitoring and controlling functions, and enable flexible manufacturing systems.

A Cornerstone in the Supply Chain of Cell-based Therapies

whitePaper | February 15, 2023

The diverse therapeutic attributes of mesenchymal stromal cells (MSCs) lend to their rapid development as cellular therapeutics. These unique attributes include potent immu nomodulatory properties [1,2], the potential to differentiate into multiple cell lineages.